Company / Income Tax
LIGAND PHARMACEUTICALS INC Income Tax History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Income Tax
$34.5M
FY2025
5-year range
-$4.1M / $41.2M
FY2021-FY2025
Trend
+426.8%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Income Tax changed +427% YoY in FY2025, a notable deviation from the 9-year average annual change of +232%.
Based on SEC 10-K filings.
$35M in FY2025 with a 3-year CAGR of -5.8%.
Increased from $10M to $35M over the past 2 years.
Income Tax over time
Growth rates
- 3-Year CAGR
- -5.8%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- 3-year CAGR of -5.8%, indicating a declining trend.
- In FY2025, income tax increased 426.8% year-over-year.
- Peak income tax was recorded in FY2019.
- Lowest income tax in the period was in FY2020.
Company context
Key Data Points
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Income TaxValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $34.5M | +426.8% |
| FY2024 | $6.5M | -33.4% |
| FY2023 | $9.8M | -76.1% |
| FY2022 | $41.2M | +1094.0% |
| FY2021 | -$4.1M | +21.8% |
| FY2020 | -$5.3M | -103.2% |
| FY2019 | $167.3M | +457.6% |
| FY2018 | $30.0M | -32.8% |
| FY2017 | $44.7M | +332.6% |
| FY2016 | $10.3M | +105.4% |
As of FY2025 · SEC 10-K · Updated Jun 29, 2026